See more : TCNS Clothing Co. Limited (TCNSBRANDS.NS) Income Statement Analysis – Financial Results
Complete financial analysis of PT Aneka Gas Industri Tbk (AGII.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Aneka Gas Industri Tbk, a leading company in the Chemicals industry within the Basic Materials sector.
- Ubon Bio Ethanol Public Company Limited (UBE.BK) Income Statement Analysis – Financial Results
- Blue Star Limited (BLUESTARCO.BO) Income Statement Analysis – Financial Results
- Marwyn Acquisition Company Plc (MACP.L) Income Statement Analysis – Financial Results
- NACL Industries Limited (NACLIND.BO) Income Statement Analysis – Financial Results
- Bud Genius, Inc. (RIGH) Income Statement Analysis – Financial Results
PT Aneka Gas Industri Tbk (AGII.JK)
About PT Aneka Gas Industri Tbk
PT Aneka Gas Industri Tbk produces, markets, and sells industrial gases in Indonesia. The company offers air gases, including oxygen, nitrogen, and argon; mixed and specialty gases comprising sulfur hexafluoride, pure gas, sterilization gas, compressed natural, environmental calibration, and exhaust emissions engine gases; synthetic gases, such as hydrogen, carbon monoxide, and sulfur dioxide; medical oxygen gas, consists nitrous oxide gas, air gas, nitrogen gas, carbon dioxide, helium, lung function mix gases, calibration gas for blood analysis, and cryopreservation gas; and hydrocarbon gases, such as propane, natural, and liquid petroleum gas, as well as acetylene; and other gases includes ammonia, samator fuel gas, and krypton, neon, and xenon rare atmospheric gases. It also provides medical supply equipment, medical gas monitoring systems, onsite gas systems, gas handling and cutting equipment, and modular operating theatre products, as well as installation services. The company operates approximately 100 filling stations. PT Aneka Gas Industri Tbk was founded in 1916 and is headquartered in Jakarta Selatan, Indonesia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,822.75B | 2,612.46B | 2,738.81B | 2,188.18B | 2,203.62B | 2,073.26B | 1,838.42B | 1,651.14B | 1,426.44B | 1,098.91B | 972.10B | 858.91B |
| Cost of Revenue | 1,582.11B | 1,456.95B | 1,507.45B | 1,254.75B | 1,205.82B | 1,133.40B | 996.82B | 887.57B | 806.10B | 609.26B | 560.42B | 484.53B |
| Gross Profit | 1,240.64B | 1,155.52B | 1,231.37B | 933.43B | 997.80B | 939.86B | 841.60B | 763.56B | 620.34B | 489.65B | 411.68B | 374.37B |
| Gross Profit Ratio | 43.95% | 44.23% | 44.96% | 42.66% | 45.28% | 45.33% | 45.78% | 46.24% | 43.49% | 44.56% | 42.35% | 43.59% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 151.34B | 129.82B | 111.98B | 104.34B | 125.48B | 124.24B | 95.75B | 93.87B | 85.80B | 75.34B | 126.97B | 105.54B |
| Selling & Marketing | 242.31B | 183.60B | 182.80B | 121.53B | 140.37B | 125.85B | 98.55B | 91.46B | 97.63B | 70.57B | 123.65B | 107.52B |
| SG&A | 680.13B | 313.43B | 294.78B | 225.87B | 265.85B | 250.09B | 194.30B | 185.33B | 183.43B | 145.91B | 250.62B | 213.06B |
| Other Expenses | 73.42B | 412.82B | 368.85B | 350.85B | 340.01B | 6.32B | 10.31B | 3.87B | 1.93B | -9.00B | 0.00 | 0.00 |
| Operating Expenses | 753.55B | 726.24B | 663.64B | 576.72B | 605.86B | 555.83B | 469.89B | 423.56B | 382.86B | 300.94B | 242.69B | 213.07B |
| Cost & Expenses | 2,354.49B | 2,183.19B | 2,171.08B | 1,831.46B | 1,811.68B | 1,689.23B | 1,466.71B | 1,311.14B | 1,188.96B | 910.20B | 803.11B | 697.61B |
| Interest Income | 17.56B | 42.38B | 44.05B | 79.72B | 63.17B | 53.35B | 39.89B | 11.72B | 5.66B | 3.09B | 64.21B | 57.76B |
| Interest Expense | 291.42B | 333.15B | 348.42B | 349.50B | 328.23B | 288.81B | 283.24B | 260.74B | 183.65B | 86.55B | 0.00 | 0.00 |
| Depreciation & Amortization | 390.76B | 382.31B | 352.59B | 300.78B | 278.47B | 258.58B | 230.83B | 201.88B | 53.90B | 43.13B | 100.63B | 72.75B |
| EBITDA | 895.40B | 855.23B | 988.70B | 752.68B | 670.03B | 641.14B | 600.40B | 541.03B | 329.57B | 318.24B | 260.82B | 232.22B |
| EBITDA Ratio | 31.72% | 22.38% | 26.82% | 24.81% | 25.12% | 24.66% | 26.29% | 25.17% | 19.63% | 19.44% | 26.83% | 27.04% |
| Operating Income | 468.26B | 466.96B | 623.03B | 440.36B | 463.62B | 384.03B | 371.71B | 340.00B | 237.48B | 188.71B | 160.18B | 159.47B |
| Operating Income Ratio | 16.59% | 17.87% | 22.75% | 20.12% | 21.04% | 18.52% | 20.22% | 20.59% | 16.65% | 17.17% | 16.48% | 18.57% |
| Total Other Income/Expenses | -255.04B | -290.43B | -291.83B | -260.54B | -253.80B | -236.39B | -237.89B | -252.08B | -167.17B | -103.43B | -56.29B | -55.93B |
| Income Before Tax | 213.22B | 138.85B | 275.90B | 96.18B | 138.14B | 147.64B | 133.82B | 87.92B | 70.32B | 85.28B | 104.78B | 103.54B |
| Income Before Tax Ratio | 7.55% | 5.31% | 10.07% | 4.40% | 6.27% | 7.12% | 7.28% | 5.32% | 4.93% | 7.76% | 10.78% | 12.05% |
| Income Tax Expense | 43.41B | 34.95B | 64.41B | -3.68B | 34.71B | 33.27B | 36.22B | 23.63B | 22.31B | 22.71B | 26.64B | 26.53B |
| Net Income | 165.41B | 88.38B | 204.18B | 96.41B | 100.97B | 99.73B | 85.57B | 54.89B | 42.26B | 54.51B | 68.73B | 65.80B |
| Net Income Ratio | 5.86% | 3.38% | 7.46% | 4.41% | 4.58% | 4.81% | 4.65% | 3.32% | 2.96% | 4.96% | 7.07% | 7.66% |
| EPS | 54.01 | 32.63 | 66.90 | 31.59 | 32.93 | 32.52 | 27.90 | 22.60 | 26.20 | 45.10 | 54.99 | 70.05 |
| EPS Diluted | 54.01 | 32.63 | 66.90 | 31.59 | 32.93 | 32.52 | 27.90 | 22.60 | 26.20 | 45.10 | 54.99 | 70.05 |
| Weighted Avg Shares Out | 3.06B | 3.04B | 3.05B | 3.05B | 3.07B | 3.07B | 3.07B | 2.42B | 1.61B | 1.57B | 1.25B | 939.32M |
| Weighted Avg Shares Out (Dil) | 3.06B | 3.04B | 3.05B | 3.05B | 3.07B | 3.07B | 3.07B | 2.42B | 1.61B | 1.61B | 1.25B | 939.32M |
Source: https://incomestatements.info
Category: Stock Reports